Reviewing FDA Guidelines During COVID-19

Episode 21

Speakers

Shannon Weatherly, Kelly Field and Zaidoon A. Al-Zubaidy

About This Episode

In this episode, we chat remotely with Catawba Research’s Director of Quality Assurance Kelly Field about how the FDA is handling clinical trials during the COVID-19 pandemic. Kelly breaks down the new FDA guidance, discussing how it addresses subject safety, compliance with GCP and other areas during this time of stay-at-home restrictions.